Cargando…

Atypical Distribution of Late Gadolinium Enhancement of the Left Ventricle on Cardiac Magnetic Resonance in Classical Anderson-Fabry Disease

Anderson-Fabry disease (AFD) is an X-linked lysosomal storage disorder caused by a deficiency of alpha-galactosidase A. Approximately 50% of patients with AFD may have cardiac involvement. Gadolinium-enhanced cardiac magnetic resonance (CMR) is useful for the diagnosis of cardiac involvement of AFD...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kasuya, Shusuke, Suzuki, Masayo, Inaoka, Tsutomu, Odashima, Masayuki, Nakatsuka, Tomoya, Ishikawa, Rumiko, Tokuyama, Wataru, Terada, Hitoshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ubiquity Press 2016
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6100657/ https://www.ncbi.nlm.nih.gov/pubmed/30151436 http://dx.doi.org/10.5334/jbr-btr.906

Ejemplares similares

Unexpected discovery of a diffuse astrocytoma of the conus medullaris in an elderly NF1 patient
por: Uchi, Takamistu, et al.
Publicado: (2020)

Biomarkers in Anderson–Fabry Disease
por: Simonetta, Irene, et al.
Publicado: (2020)

Cardiac abnormalities in Anderson-Fabry disease and Fabry’s cardiomyopathy
por: Morrissey, Ryan P, et al.
Publicado: (2011)

The distribution of hypertrophy in anderson fabry disease
por: Sado, Daniel M, et al.
Publicado: (2011)

Anderson-Fabry disease in heart failure
por: Akhtar, M. M., et al.
Publicado: (2018)

Discrimination of dementia with Lewy bodies from Alzheimer’s disease using voxel-based morphometry of white matter by statistical parametric mapping 8 plus diffeomorphic anatomic registration through exponentiated Lie algebra
por: Nakatsuka, Tomoya, et al.
Publicado: (2013)

Clinical prodromes of neurodegeneration in Anderson-Fabry disease
por: Löhle, Matthias, et al.
Publicado: (2015)

Role of cardiac imaging in Anderson-Fabry cardiomyopathy
por: Serra, Walter, et al.
Publicado: (2019)

Pathologic substrate of gastropathy in Anderson-Fabry disease
por: Di Toro, Alessandro, et al.
Publicado: (2020)

Agalsidase alfa (Replagal(™)) in the treatment of Anderson-Fabry disease
por: Pastores, Gregory M
Publicado: (2007)

Time of Anderson-Fabry Disease Detection and Cardiovascular Presentation
por: Selthofer-Relatic, K.
Publicado: (2018)

CMR demonstration of multiple morphological phenotypes in Anderson-Fabry disease
por: Deva, Djeven P, et al.
Publicado: (2015)

Gastrointestinal Involvement in Anderson-Fabry Disease: A Narrative Review
por: Caputo, Fabio, et al.
Publicado: (2021)

Cardiac Imaging in Anderson-Fabry Disease: Past, Present and Future
por: Esposito, Roberta, et al.
Publicado: (2021)

Anderson–Fabry Disease: From Endothelial Dysfunction to Emerging Therapies
por: Stamerra, Cosimo A., et al.
Publicado: (2021)

Advanced CMR Techniques in Anderson-Fabry Disease: State of the Art
por: Ponsiglione, Andrea, et al.
Publicado: (2023)

A classical phenotype of Anderson-Fabry disease in a female patient with intronic mutations of the GLA gene: a case report
por: Pisani, Antonio, et al.
Publicado: (2012)

Angiokeratoma Corporis Diffusum: An Uncommon Case with Suspected Anderson Fabry Disease
por: Vadher, Priyanka, et al.
Publicado: (2020)

Anderson-fabry disease: role of traditional and new cardiac MRI techniques
por: Caredda, Gloria, et al.
Publicado: (2021)

Mutations in the GLA Gene and LysoGb3: Is It Really Anderson-Fabry Disease?
por: Duro, Giovanni, et al.
Publicado: (2018)

Anderson-Fabry’s Disease: A Rare but Treatable Case of Fever of Unknown Origin
por: Graziani, Francesca, et al.
Publicado: (2017)

Clinical Diversity in Patients with Anderson-fabry Disease with the R301Q Mutation
por: Yamamoto, Saori, et al.
Publicado: (2018)

Biomarkers and Imaging Findings of Anderson–Fabry Disease—What We Know Now
por: Beirão, Idalina, et al.
Publicado: (2017)

Prognostic significance of right ventricular hypertrophy and systolic function in Anderson–Fabry disease
por: Graziani, Francesca, et al.
Publicado: (2020)

Does left ventricular function predict cardiac outcome in Anderson–Fabry disease?
por: Spinelli, Letizia, et al.
Publicado: (2020)

Evidence of evolution towards left midventricular obstruction in severe Anderson–Fabry cardiomyopathy
por: Graziani, Francesca, et al.
Publicado: (2020)

Radiofrequency ablation of ventricular tachycardia in Anderson–Fabry disease: a case series
por: Mills, Mark T, et al.
Publicado: (2021)

Anderson–Fabry Disease: A New Piece of the Lysosomal Puzzle in Parkinson Disease?
por: Zedde, Marialuisa, et al.
Publicado: (2022)

Left atrial strain correlates with severity of cardiac involvement in Anderson-Fabry disease
por: Halfmann, Moritz C., et al.
Publicado: (2022)

Sex Differences in Anderson–Fabry Cardiomyopathy: Clinical, Genetic, and Imaging Analysis in Women
por: Faro, Denise Cristiana, et al.
Publicado: (2023)

Transcatheter Tricuspid Valve Replacement for Anderson Fabry Disease With Severe Tricuspid Regurgitation
por: Zhou, Guang-Wei, et al.
Publicado: (2022)

Reduced coronary flow reserve in Anderson-Fabry disease measured by transthoracic Doppler echocardiography
por: Dimitrow, Paweł Petkow, et al.
Publicado: (2005)

Evaluating enzyme replacement therapies for Anderson-Fabry disease: commentary on a recent report
por: Giugliani, Roberto, et al.
Publicado: (2018)

Anderson-Fabry disease cardiomyopathy: an update on epidemiology, diagnostic approach, management and monitoring strategies
por: Averbuch, Tauben, et al.
Publicado: (2023)

Diverse phenotypic expression associated with the same genetic variant in female heterozygote patients of Anderson–Fabry disease: a case series
por: Tomioka, Daisuke, et al.
Publicado: (2021)

Reduced native right ventricular T(1 )in Anderson-Fabry disease as compared to patients with pulmonary hypertension
por: Pagano, Joseph J, et al.
Publicado: (2014)

Inter-familial and intra-familial phenotypic variability in three Sicilian families with Anderson-Fabry disease
por: Tuttolomondo, Antonino, et al.
Publicado: (2017)

Association between Left Atrial Deformation and Brain Involvement in Patients with Anderson-Fabry Disease at Diagnosis
por: Esposito, Roberta, et al.
Publicado: (2020)

Pathogenesis and Molecular Mechanisms of Anderson–Fabry Disease and Possible New Molecular Addressed Therapeutic Strategies
por: Tuttolomondo, Antonino, et al.
Publicado: (2021)

Electrocardiogram analysis in Anderson-Fabry disease: a valuable tool for progressive phenotypic expression tracking
por: Parisi, V., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_27gdi6i4mm48kjsi718lno2e59